Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ostrowski

Showing results (201-210 of 248) with videos related to

Pageof 25
Sort By:
The Journal of Biological Chemistry|May 18, 1999
Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K proteinD S Schullery, J Ostrowski, O N Denisenko, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic studyR Bergstrand, A Vedin, C Wilhelmsson, et al.
The Journal of Biological Chemistry|March 5, 1992
Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanismS B Liggett, J Ostrowski, L C Chesnut, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1993
Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiencyJ Sennesael, D Verbeelen, S Degré, et al.
The Journal of Biological Chemistry|July 5, 1991
A serine/threonine kinase activity is closely associated with a 65-kDa phosphoprotein specifically recognized by the kappa B enhancer elementJ Ostrowski, J E Sims, C H Sibley, et al.
Journal of Chromatography|June 29, 1990
Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatographyC Dutot, J Moreau, P Cordonnier, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patientsK Przytulski, J Regula, A Dziurkowska-Marek, et al.
The EMBO Journal|March 15, 1995
RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferationJ Y Chen, S Penco, J Ostrowski, et al.
Plos One|August 15, 2017
Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitroSevasti Zervou, Hannah J Whittington, Philip J Ostrowski, et al.
Arzneimittel-Forschung|January 1, 1981
Absorption and disposition of [14C]-molsidomine in laboratory animalsJ M Fromson, H P Illing, R M Ings, et al.
Pageof 25

Showing results (201-210 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Biological Chemistry|May 18, 1999
Regulated interaction of protein kinase Cdelta with the heterogeneous nuclear ribonucleoprotein K proteinD S Schullery, J Ostrowski, O N Denisenko, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic studyR Bergstrand, A Vedin, C Wilhelmsson, et al.
The Journal of Biological Chemistry|March 5, 1992
Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanismS B Liggett, J Ostrowski, L C Chesnut, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1993
Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiencyJ Sennesael, D Verbeelen, S Degré, et al.
The Journal of Biological Chemistry|July 5, 1991
A serine/threonine kinase activity is closely associated with a 65-kDa phosphoprotein specifically recognized by the kappa B enhancer elementJ Ostrowski, J E Sims, C H Sibley, et al.
Journal of Chromatography|June 29, 1990
Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatographyC Dutot, J Moreau, P Cordonnier, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patientsK Przytulski, J Regula, A Dziurkowska-Marek, et al.
The EMBO Journal|March 15, 1995
RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferationJ Y Chen, S Penco, J Ostrowski, et al.
Plos One|August 15, 2017
Increasing creatine kinase activity protects against hypoxia / reoxygenation injury but not against anthracycline toxicity in vitroSevasti Zervou, Hannah J Whittington, Philip J Ostrowski, et al.
Arzneimittel-Forschung|January 1, 1981
Absorption and disposition of [14C]-molsidomine in laboratory animalsJ M Fromson, H P Illing, R M Ings, et al.
Pageof 25